Discover
XGN
Exagen Inc.
4.71
2 x 3.40
2 x 5.95
bid
ask
+
0.06
1.29%
2 @ 04:00 PM
4.71 +0.00 (0.00%)
| Ytd | -22.53% | |
| 1y | -32.62% |
4.57
day range
4.82
2.59
52 week range
12.23
| Open | 4.65 | Prev Close | 4.65 | Low | 4.57 | High | 4.82 | Mkt Cap | 113.79M |
| Vol | 82.80K | Avg Vol | 388.22K | EPS | -0.90 | P/E | N/A | Forward P/E | -5.96 |
| Beta | 1.35 | Short Ratio | 3.12 | Inst. Own | 57.22% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-04 | 50-d Avg | 3.97 | 200-d Avg | 5.89 | 1yr Est | 6.25 |
XGN News
benzinga.com
Roth Capital Initiates Coverage On Exagen with Buy Rating, Announces Price Target of $8
Roth Capital analyst Max Masucci initiates coverage on Exagen (NASDAQ:XGN) with a Buy rating and
benzinga.com
Exagen Announces Publication Of New Systematic Review Demonstrating That AVISE Lupus Algorithm Deliv
Uniquely identified ~25% of the SLE patients who would otherwise be missed by conventional markersDe